Introduction
============

Sperm capacitation process can be defined as the biochemical, biophysical, molecular, and metabolic changes of the sperm cell that confers the ability to fertilize an oocyte *in vivo* or *in vitro* ([@B001]). In bovines, heparin, a glycosaminoglycan present in the female reproductive tract, has been considered the primary substance that promotes sperm capacitation *in vitro* ([@B027]; [@B005]; [@B028]). Through the penetration test on denuded homologous oocytes, the absence of heparin after 4 hours of culture demonstrated that only 31% of bovine spermatozoa could capacitate ([@B026]).

For improving the *in vitro* sperm capacitation, various substances have been used together with the fertilization media, such as L-arginine (L-arg) ([@B025]; [@B031]; [@B032]). L-arg plays a significant role in sperm motility, capacitation process, and induces acrosome reaction in cattle ([@B025]; [@B020]; [@B034]). Such effects have been linked to the synthesis of nitric oxide (NO) from L-arg by the sperm cell ([@B025]; [@B020]). In a previous study of our group, we demonstrated that the concentration of 1 mM L-arg + heparin was the most effective to improve sperm capacitation after 4 hours of incubation using cryopreserved sperm ([@B021]).

Nitric oxide is a reactive nitrogen species (RNS) that can act in inter and intracellular signaling, and as an antioxidant or free radical ([@B009]). Nitric oxide is synthesized during the conversion of L-arg into L-citrulline in oxidative reactions. Although L-arg has been widely used in sperm capacitation ([@B014]; [@B025]; [@B020]), most of the studies do not evaluate its effect after capacitation, such as the *in vitro* embryo production. In a recent publication, L-arg improved embryonic developmental rates in cattle when added to the medium of IVF ([@B033]). Although common IVF medium is enriched to stimulate sperm capacitation, in this model, L-arg could influence both sperm and COCs.

Hence, we aimed to evaluate the effects of L-arg in the quality of *in vitro* heparin-induced capacitation of cryopreserved bovine spermatozoa and its effects on IVP to use L-arg on *in vitro* heparin-induced sperm capacitation of cattle and further evaluate its effects on the *in vitro* embryo production. For this, we investigated the plasma membrane integrity and the capacitation status of the sperm and we assess the sperm quality by the rate of blastocysts produced *in vitro*. With this, we hope to contribute in the study of the role of NO during bovine sperm capacitation and its impact on the *in vitro* produced embryos.

Materials and methods
=====================

Culture media
-------------

All reagents used in these experiments were obtained from Sigma-Aldrich Brasil Ltda (São Paulo, SP, Brazil) unless otherwise indicated. The media used in the process of *in vitro* embryo production were obtained from Progest Biotecnologia em Reprodução Animal (Botucatu, SP, Brazil).

Sperm preparation and selection
-------------------------------

The mini Percoll gradient was used for separation of viable spermatozoa after being thawed. For the 90% fraction, we used 540 µL of commercial Percoll (Amersham Pharmacia Biotech Ltda, Little Chalfont, UK) and 60 µL of 10× TALP. The fraction 45% was prepared by adding 200 µL of 90% Percoll and 200 µL of TALP Chamberland with 1% PVA ([@B005]). For the preparation of the mini Percoll gradient, the fraction of 45% was gently placed on the fraction of 90% in a 1.5 mL microtube.

Cryopreserved sperm were thawed and subjected to centrifugation at 700 × *g* for 5 min on mini Percoll gradient 45/90% ([@B011]). After centrifugation, the pellet was washed for 3 min (150 × *g*) in 400 µL of TALP Chamberland. The sperm motility and vigor were evaluated for quality confirmation, and then the sperm concentration was determined using a Neubauer chamber. The selected sperm were transferred to the respective capacitation tubes.

Sperm capacitation
------------------

The medium used in the capacitation was modified Tyrodes ([@B027]) supplemented with 6 mg/mL BSA, fatty acids free, 100 IU/mL penicillin and 100 µg/mL streptomycin, and containing 20 µg/mL heparin (except TL-arg), with or without 1 mM L-arginine ([@B021]) in an incubator at 38.5°C in humidified atmosphere of 95% air and 5% CO~2~. Sperm concentration was adjusted to 10 × 10^6^ sperm/mL for sperm evaluations and was adjusted to 2 × 10^6^ sperm/mL for *in vitro* fertilization.

The sperm capacitation was induced in 30 min of cultivation in the absence of COC for both experiments. In Experiment 1, we evaluated the acrosome and plasma membrane sperm integrity and the percentage of capacitated sperm. In Experiment 2, we tested the treatments (T-Hep, TL-arg, and TL-arg + Hep) on IVF to evaluate the rate of *in vitro* blastocysts production. The sperm capacitation in the presence of COC was only induced in the Control group with heparin (Control IVF).

Simultaneous assessment of plasma membrane integrity
----------------------------------------------------

After the capacitation in absence of COC for 30 min and in the Control group 0 hour, an aliquot of 50 µL of sperm (25 × 10^6^ sperm/mL) was exposed to the Hoechst 33342 (40 mg/mL) and PI (0.5 µg/mL) for 5 min to observe the plasma membrane integrity ([@B004]). Then, the sample was observed under an epifluorescence microscope (NIKON - Eclipse TE300, Melville, NY, USA) at 400× magnification. All samples were evaluated within 30 min.

The PI binds to the DNA of cells with damage in the plasma membrane ([@B016]) and stains the nucleus red, while the Hoechst binds to the DNA of all cells and stains the nucleus blue ([@B003]). Four replicates of four different bulls, we analyzed with at least 200 cells counted (n=3200). The sperm membrane was classified as intact or damaged for each cell.

Assessment of sperm capacitation by fluorescent chlortetracycline assay (CTC)
-----------------------------------------------------------------------------

The sperm capacitation was assessed by chlortetracycline hydrochloride (CTC) modified by [@B006]. The CTC stock solution (0.75 mM CTC, 20 mM Tris-base, and 5 mM DL-cysteine) was prepared on the day of use. We added 15 µL of the final CTC solution \[300 µL of CTC stock solution mixed with 10 µL of paraformaldehyde (4%) in 20 mM Tris base and 60 µL of octane diazabicyclo - DABCO (Invitrogen Molecular Probe, Eugene, OR, USA)\] to 15 µL of sperm (25 × 10^6^ spermatozoa/mL) followed by 15 min incubation at room temperature. The sample was observed under an epifluorescence microscope (NIKON - Eclipse TE300, Melville, NY, USA; 40× - excitation 440 nm and emission at 470 nm). All samples were evaluated within 30 min.

Four replicates of each bull were analyzed with at least 200 cells counted (n=3200) and classified into 3 groups, as described by [@B012]: F (fluorescent), intact and non-capacitated sperm with entire fluorescing surface, C (capacitated) fluorescence loss in post-acrosomal region, and RA, sperm with reacted acrosome showing fluorescence loss in post-acrosome and acrosome region with fluorescence exclusively in the middle part and equatorial region of the head.

Assessment of the quality of sperm capacitation by the in vitro production of blastocysts
=========================================================================================

### Selection and in vitro maturation of oocytes

Oocytes were selected with grades 1 and 2 ([@B008]) from ovaries obtained from local abattoirs. These ovaries were transported to the laboratory within 1 hour in thermo bottles containing 0.9% NaCl sterile saline at 38.5ºC and antibiotics (100 IU/mL penicillin and 100 µg/mL streptomycin). After being selected, the oocytes were washed 3 to 4 times in the Progest wash medium (Progest Biotecnologia em Reprodução Animal, Botucatu, SP, Brazil) and then transferred to the maturation plate.

The medium used for *in vitro* maturation was Progest *in vitro* Maturation (Progest Biotecnologia em Reprodução Animal, Botucatu, SP, Brazil). Maturation was carried out in Petri dishes (35x10mm, Corning Inc. Acton, MA, USA) with droplets of 100 µL immersed in mineral oil (1 oocyte/5 µL of medium) in an incubator at 38.5°C under an atmosphere of 5% CO~2~ for 22 hours.

### In Vitro Fertilization (IVF)

Sperm selected by mini Percoll were washed for 3 min (150 × *g*) in TALP Chamberland, and the sperm concentration was determined in a Neubauer chamber to detect the fertilization dose used for IVF (2 × 10^6^ spermatozoa/mL).

The sperm were added to IVF drops of 50 µL, with one plate being used for each treatment, where they remained co-incubated with oocytes for 18 hours under the same conditions of IVM in medium Progest *in vitro* Fertilization (Progest Biotecnologia em Reprodução Animal, Botucatu, SP, Brazil).

### In Vitro Culture (IVC)

The IVC medium used was Progest *in vitro* Culture (Progest Biotecnologia em Reprodução Animal, Botucatu, SP, Brazil). After 20 hours, the presumptive zygotes were submitted to consecutive pipetting for partial removal of the cumulus cells and spermatozoa. After that, the zygotes were transferred to drops of IVC (1 zygote/5 µL of medium) and remained incubated for 7 days at 38.5°C with a humidified atmosphere of 95% air and 5% CO~2~.

After 72 hours of cultivation, it was carried out a replacement of 60% of the culture medium (feeding). The cleavage rate was assessed 48 hours after IVF, which were considered cleaved embryos that had two or more cells without signs of fragmentation or cell degeneration. At day 7 (D7), we observed the blastocyst rate according to the criteria recommended by the International Embryo Transfer Society ([@B030]).

### Statistical analysis

Data were subjected to analysis of variance (ANOVA) to determine the effects of treatments in the studied characteristics and the averages were compared by Tukey test at 5% probability ([@B035]).

Results
=======

Quantitative evaluation of sperm capacitation by fluorescent chlortetracycline assay (CTC)
------------------------------------------------------------------------------------------

The percentage of non-capacitated sperm was higher (P\<0.05) in the Control 0 hour (68.4 ± 5.1%) when compared to the capacitation with L-arg (45.8 ± 4.3%), Hep (25.8 ± 3.4%) and L-arg + Hep (19.2 ± 1.5%). Treatment with L-arg + Hep in the absence of COC showed the highest percentage of capacitated sperm (61.2 ± 1.2%), differing from treatments with Hep, L-arg, and the Control 0 hour (47.0 ± 4.0%, 26.2 ± 3.8%, and 18.2 ± 4.5%, respectively) (P\<0.05).

The percentage of sperm with reacted acrosome (RA) was lower (P\<0.05) in the Control 0 hour (13.7 ± 2.6%), followed by treatment with L-arg + Hep (19.6 ± 1.1%), Hep (25.2 ± 3.3%) and L-arg (29.9 ± 5.2%) in the absence of COC. These results are summarized in [Figure 1](#gf01){ref-type="fig"}.

![Percentage of non-capacitated sperm, capacitated, and acrosome reacted in treatments in the absence of COCs: Control 0hour, 30 min capacitation with heparin, 30 min capacitation with L-arginine, and 30 min capacitation with L-arginine + heparin. Data are presented as mean ± CI (confidence interval, P\<0.05) of four repetitions from four bulls (n=3200 sperm). Different letters indicate statistical differences between treatments for the studied pattern according to the Tukey test. In each repetition, 200 sperm cells were counted. The numbers in bold at the bottom of each bar represent the mean observed in each treatment.](1984-3143-ar-16-4-938-gf01){#gf01}

Assessment of plasma membrane integrity
---------------------------------------

The statistical analysis showed no statistically significant differences in the percentage of spermatozoa with intact plasma membrane between treatments after 30 min of capacitation (Control 0 hour: 66.8 ± 7.0%; T-Hep: 67.5 ± 5.1%; TL-arg: 67.2 ± 6.5%; TL-arg + Hep: 67.4 ± 6.4%).

Assessment of the quality of sperm capacitation by the in vitro blastocysts production
--------------------------------------------------------------------------------------

There was no statistically significant difference between the percentage of cleaved embryos of Control IVF when the sperm were capacitated with heparin in the presence of COC (78.0 ± 3.2%) and the treatments that were capacitated in the absence of COC with L-arg + Hep (82.2 ± 3.5%) or Hep (79.3 ± 4.2%, P\>0.05). However, these groups differed from the group with L-arg in the absence of COC (64.4 ± 7.3%, P\<0.05).

The blastocyst production of the group with L-arg + Hep in the absence of COC (53.7 ± 4.1%) was higher when compared to the group capacitated with heparin in the Control IVF (40.8 ± 3.9%, P\<0.05). Additionally, we did not observe differences between the group with L-arg + Hep in the absence of COC and group heparin (47.4 ± 4.8%). The group capacitated with L-arg showed the lowest blastocyst rate (30.0 ± 5.4%), different from the other treatments (P\<0.05). These results are summarized in [Figure 2](#gf02){ref-type="fig"}.

![Percentage of cleaved embryos and blastocysts in the following treatments: capacitation with Hep in the presence of COCs (Control IVF), capacitation with Hep in the absence of COCs, capacitation with L-arg in absence COC, and capacitation with L-arg + Hep in the absence of COCs. Data are presented as mean ± CI (confidence interval P\<0.05) of six replicates from four bulls (24 IVF trials, n=2340 COCs). Different letters indicate statistical differences between treatments for the developmental stage according to the Tukey test (P\<0.05). The numbers in bold at the bottom of each bar represent the mean observed in each treatment.](1984-3143-ar-16-4-938-gf02){#gf02}

Discussion
==========

In cattle, nitric oxide plays a fundamental role in the sperm capacitation process ([@B025]; [@B031]; [@B020]). Although the sperm can synthesize NO during capacitation, recent studies demonstrate that exogenous increase of NO from the inclusion of L-arg to the capacitation medium improves sperm quality in a dose-dependent manner during incubation ([@B020]; [@B019]). The availability of L-arg for NO synthesis is determined *in vitro* mainly by L-arg concentration in the culture medium used ([@B018]). Moreover, *in vivo,* the capacitation process occurs throughout the female reproductive tract, especially in the oviduct, where a sperm reservoir is formed ([@B017]). In the same way, the primary source of NO production for the sperm capacitation *in vivo* originates from the female reproductive tract ([@B022]), being concordant with the improvement observed by the addition of L-arg to the capacitating medium. Although the NO dosage has not been performed in our research, many studies demonstrate the NO synthesis by cattle sperm using L-arg as a substrate during the *in vitro* capacitation ([@B020]; [@B021]; [@B033]).

Here we used 1 mM L-arg in the capacitation medium in absence of COC for 30 min, as we previously showed for improving sperm capacitation ([@B021]).We observed that the inclusion of L-arg to the capacitation medium containing heparin increased the percentage of capacitated sperm and kept down the percentage of sperm that presented acrosome reaction and that was non-capacitated. The results of this study are consistent with those we reported ([@B021]) at 4 hours of capacitation.

Spermatozoa with a high percentage of acrosome reaction at the time of insemination showed low fertility ([@B007]) that may result in a decrease in the cleavage rate. Thus, the increase in the percentage of non-capacitated and acrosome-reacted sperm in L-arg group may have contributed to the decline in the fertilizing potential of the sperm, and consequently on the rate of the *in vitro* production of blastocysts.

During the sperm capacitation of mammals, NO acts in the cAMP and the extracellular-regulated kinase (ERK) signaling pathways ([@B015]). Heparin primarily acts in the membrane ([@B028]), which facilitates the entry of ions, especially calcium. Ca^2+^ intake leads to an increase in the intracellular pH and consequently hyperactivation ([@B028]; [@B015]). The increase of Ca^2+^ and NO concentrations activates the soluble adenylate cyclase (sAC), stimulating the cAMP synthesis and protein tyrosine phosphorylation through protein kinase A (PKA). As reviewed by [@B015], the extracellular-regulated kinase (ERK) plays a role in the sperm capacitation, motility, and acrosome reaction. In the intracellular environment, ERK is activated by NO, leading to protein tyrosine phosphorylation ([@B015]). Thus, L-arg may stimulate the ERK pathway and potentialize the cAMP pathway. More studies are needed to address this hypothesis in bovine.

In this study, no difference in sperm was observed between Control 0 hour and the groups treated in the absence of COC for 30 min, which showed intact membrane. It is worth noting that the average of sperm that had intact membrane was about 67%, similar to the percentage of capacitated sperm in the presence of L-arg + Hep (61%). This observation suggests that almost all the sperm that presented plasma membrane integrity were eligible for *in vitro* capacitation. Since ionic events, such as changes in intracellular concentration of Ca^2+^, H^+^ ([@B029]), and HCO~3~ ^-^ ([@B002]) modulate the capacitation, only spermatozoa with plasma and acrosomal membrane integrity can be capacitated.

On *in vitro* embryo production, no difference was observed in the cleavage rate between treatments with heparin in the absence of COC comparing to Control IVF, corroborating with the results obtained by [@B033] and [@B021]. The group treated with L-arg demonstrated the lowest cleavage rate, as well as the lowest rate of capacitation and *in vitro* production of embryos. These data corroborate with those obtained by [@B026], which demonstrate that, in the presence of 10^-9^ M sodium nitroprusside (SNP, NO donor), the penetration rate of oocytes by capacitated spermatozoa is reduced when spermatozoa are treated with heparin. [@B033] found no additive beneficial effect of these capacitation agents, although they have been tested on the capacitation in the presence of COCs (traditional method). Therefore, in this method used by the authors, the L-arg could be acting both on sperm ([@B020]) and COCs ([@B010]), and thus this result indicate that the observed effect was not exclusively by the action of L-arg in sperm capacitation.

The increase in the blastocyst rate in the capacitation group with L-arg + Hep in the absence of COCs in comparison with Control IVF and T-Hep may occur due to the greater number of capacitated sperm in addition to the reduced level of acrosome-reacted sperm. Prior to fertilization *in vitro*, the sperm cells ([@B020], [@B021]) and the COCs ([@B036]; [@B024]) synthesize NO, similarly as in the oviduct ([@B022]). Moreover, the female reproductive tract also produces heparin ([@B013]), also relevant to the capacitation process. In this study, we demonstrate that the treatment with L-arg + Hep could mimic the female reproductive environment *in vitro*. With this reasoning, we previously demonstrated that using L-arg in addition of heparin in the capacitation media 41 proteins were differentially abundant compared to control (only with heparin). Many of these proteins being associated with key roles in sperm capacitation, fertilization and embryonic development ([@B023]).

The L-arg + Hep capacitation method performed in the absence of the COC has proven effective in the evaluation of different treatments on the capacitation. This observation indicates that the oocytes were not influenced by L-arg and heparin during the fertilization process due to removal of treatments after 30 min.

Thus, our findings indicate that the addition of L-arg to capacitation medium containing heparin increases the number of *in vitro* capacitated sperm and decreases the number of non-capacitated and acrosome-reacted sperm with 30 min of culture in the absence of COCs. Moreover, these experiments have shown no interference on the percentage of sperm showing plasma membrane intact. Furthermore, the addition of L-arg in the capacitation medium with heparin in the absence of COCs was the most efficient method of blastocysts *in vitro* production in cattle. Since this pre-incubation method in absence of COC was the most effective, we further emphasize that it could be used to assess the role of other substances in the sperm capacitation and its effect on IVP.
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